Proactive Investors - Run By Investors For Investors

Ascent Industries says it’s committed to ‘constructive dialogue’ with shareholders

The company confirms receiving request for general meeting regarding the board's makeup
A board table
The cannabis company says it’s focused on the highest standards of corporate governance

Ascent Industries Corp (CSE:ASNT) said Monday the company is “committed to constructive dialogue and engagement” after receiving a request from investor Drew Malcolm to hold a shareholder meeting regarding the makeup of its board.

The cannabis company said in a statement that it’s focused on the highest standards of corporate governance and making decisions for the benefit of all shareholders.

READ: Ascent Industries has until February 20 to make additional submissions to Health Canada

Malcolm said in a statement over the weekend that shareholders controlling 44.8% of the outstanding common shares are seeking the removal of three incumbent directors and the election of seven new independent directors who would constitute the entire board.

“Ascent's current management and board of directors are committed to constructive dialogue and engagement with both the Malcolm Group as well as independent shareholders,” Ascent said.

The company declined to provide further comment.

Last week, Ascent said Health Canada had advised the company that the agency still intends to revoke a subsidiary’s licenses and has given Ascent until February 20 to make any additional submissions.

Shares of Ascent slipped C$0.01 to C$0.14 in Monday’s Canadian trading.

Contact Dennis Fitzgerald at [email protected]

Join Proactive’s Crypto, Blockchain and Cannabis Telegram group here
View full ASNT profile View Profile

Ascent Industries Corp. Timeline

Article
November 23 2018

Related Articles

Cannabis leaf
November 19 2018
With the legalisation of recreational cannabis in Canada in October, and the US expected to follow suit, the company has its sights set on building up the very best in the industry
The R&D programme is intended to address the increasing prevalence of obesity and diabetes using smart siRNA
October 31 2018
The health sciences company noted that the plan was formulated at a recently held two-day intensive workshop which together leading scientific teams from the QIMR Berghofer Medical Research Institute in Brisbane and Murdoch University in Perth
Sydney Harbour Bridge
January 23 2019
A phase I study in Australia is evaluating a cannabis spray therapeutic in cancer patients.

© Proactive Investors 2019

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use